Low expression of miR-150 in pediatric intestinal Burkitt lymphoma

Experimental and Molecular Pathology

Volumn 96, Issue 2, 2014, Pages 261-266

  Wang, Miao ^a   Yang, Wenping ^b   Li, Min ^c   Li, Yong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Jiangxi Children's Hospital   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Burkitt lymphoma; ISH; MiR 150; QRT PCR; Reactive lymphoid hyperplasia

Indexed keywords

MICRORNA; MICRORNA 150; PROTEIN C MYB; SURVIVIN; UNCLASSIFIED DRUG; MIRN150 MICRORNA, HUMAN;

ARTICLE; BURKITT LYMPHOMA; CELL GROWTH; CHILD; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOID HYPERPLASIA; MALE; MOLECULAR PATHOLOGY; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR LOCALIZATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; INTESTINE TUMOR; PATHOLOGY; PRESCHOOL CHILD; TUMOR CELL LINE;

BURKITT LYMPHOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINAL NEOPLASMS; MALE; MICRORNAS;

EID: 84896360431     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.02.015     Document Type: Article

References (26)

1. Bornkamm G.W. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int. J. Cancer 2009, 124:1745-1755.
2. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
3. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A., Mendell J.T. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 40:43-50.
4. Chen S., Wang Z., Dai X., Pan J., Ge J., Han X., Wu Z., Zhou X., Zhao T. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro. Cancer Sci. 2013, 104(2013):826-834.
5. Chuang S.S., Ye H., Du M.Q., Lu C.L., Dogan A., Hsieh P.P., Huang W.T., Jung Y.C. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. Am. J. Clin. Pathol. 2007, 128:558-564.
6. Di N.M., Carlo-Stella C., Mariotti J., Devizzi L., Massimino M., Cabras A., Magni M., Matteucci P., Guidetti A., Gandola L., Gianni A.M. High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults. Br. J. Haematol. 2004, 126:815-820.
7. Fallon S.C., Redell M.S., El-Bietar J., Lopez M.E., Vasudevan S.A., Brandt M.L. Intestinal perforation after treatment of Burkitt's lymphoma: case report and review of the literature. J. Pediatr. Surg. 2013, 48:436-440.
8. Ferracin M., Pedriali M., Veronese A., Zagatti B., Gafa R., Magri E., Lunardi M., Munerato G., Querzoli G., Maestri I., Ulazzi L., Nenci I., Croce C.M., Lanza G., Querzoli P., Negrini M. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J. Pathol. 2011, 225:43-53.
9. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
10. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., Hammond S.M. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
11. Karpova M.B., Schoumans J., Ernberg I., Henter J.I., Nordenskjold M., Fadeel B. Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line. Leukemia 2005, 19:159-161.
12. Li Y., Huang S., Wang X., Zhou D., Huang K., Guo H., Fang J., Chen C., Liu Q. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma. J. Trop. Pediatr. 2010, 56:337-341.
13. Li X., Chen J., Hu X., Huang Y., Li Z., Zhou L., Tian Z., Ma H., Wu Z., Chen M., Han Z., Peng Z., Zhao X., Liang C., Wang Y., Sun L., Chen J., Zhao J., Jiang B., Yang H., Gui Y., Cai Z., Zhang X. Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events. PLoS One 2011, 6:e22570.
14. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
15. Lu B., Zhou C., Yang W., Huang H., Gao Z., He Y., Liu H., Zhou X., Gong L. Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients. Leuk. Lymphoma 2011, 52:2356-2364.
16. Lyng M.B., Laenkholm A.V., Sokilde R., Gravgaard K.H., Litman T., Ditzel H.J. Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. PLoS One 2012, 7:e36170.
17. Ma Y., Zhang P., Wang F., Zhang H., Yang J., Peng J., Liu W., Qin H. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut 2012, 61:1447-1453.
18. Molyneux E.M., Rochford R., Griffin B., Newton R., Jackson G., Menon G., Harrison C.J., Israels T., Bailey S. Burkitt's lymphoma. Lancet 2012, 379:1234-1244.
19. Nakata Y., Shetzline S., Sakashita C., Kalota A., Rallapalli R., Rudnick S.I., Zhang Y., Emerson S.G., Gewirtz A.M. c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression. Mol. Cell Biol. 2007, 27:2048-2058.
20. Osier F.H., Berkley J.A., Newton C.R. Life-threatening hyponatraemia and neurotoxicity during chemotherapy for Burkitt's lymphoma. Trop. Dr. 2006, 36:177-178.
21. Robertus J.L., Kluiver J., Weggemans C., Harms G., Reijmers R.M., Swart Y., Kok K., Rosati S., Schuuring E., van I.G., Pals S.T., Kluin P., van den Berg A. MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br. J. Haematol. 2010, 149:896-899.
22. Tan L.P., Wang M., Robertus J.L., Schakel R.N., Gibcus J.H., Diepstra A., Harms G., Peh S.C., Reijmers R.M., Pals S.T., Kroesen B.J., Kluin P.M., Poppema S., van den Berg A. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab. Invest. 2009, 89:708-716.
23. Wang M., Atayar C., Rosati S., Bosga-Bouwer A., Kluin P., Visser L. JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125. J. Pathol. 2009, 218:95-103.
24. Wang M., Zhou C., Sun Q., Cai R., Li Y., Wang D., Gong L. ALK amplification and protein expression predict inferior prognosis in neuroblastomas. Exp. Mol. Pathol. 2013, 95:124-130.
25. Watanabe A., Tagawa H., Yamashita J., Teshima K., Nara M., Iwamoto K., Kume M., Kameoka Y., Takahashi N., Nakagawa T., Shimizu N., Sawada K. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011, 25:1324-1334.
26. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., Rajewsky N., Bender T.P., Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.